COMP <GO>
IRON vs MRK // FREE CASH FLOW YIELD
Disc Medicine Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: IRON 3
— MRK 10
▲ FREE CASH FLOW YIELD LEADER: MRK
LAST: $80.84 (-2.41%) • MKT CAP: $3.68B
fcf-yield
-4.93%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRON VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRON | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -27.50% | 20.70% | -48.20 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -4.93% | 3.42% | -8.35 | MRK | /fcf-yield <GO> |
| Operating Margin | -22.90% | 34.30% | -57.20 | MRK | /operating-margins <GO> |
| Net Profit Margin | -20.60% | 28.10% | -48.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 1.30% | +15.20 | IRON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 5.19 | +20.81 | IRON | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.8 | 56.9 | +7.94 | IRON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.92 | -0.02 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.0x | 18.4x | +1.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.68B | $361.02B | -$357.34B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRON REV | MRK REV | IRON GROSS % | MRK GROSS % | IRON FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $65.01B | — | 74.8% | -$181.3M | $12.36B |
| FY 2024 | $0 | $64.17B | — | 76.3% | -$94.4M | $18.10B |
| FY 2023 | $0 | $60.12B | — | 44.0% | -$73.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRON // BETA 0.90
MRK // BETA 0.92